Economic Analysis of Rapid Multiplex Polymerase Chain Reaction Testing for Meningitis/Encephalitis in Pediatric Patients
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Aim: We assessed the possible economic impact of a rapid test in pediatric patients with suspected community-acquired meningitis/encephalitis. Materials & methods: Modeling simulated diagnosis, clinical decisions, resource use/costs of standard of care (SOC) and two cerebrospinal fluid testing strategies using FilmArray® (FA), a US FDA-cleared system that provides results in approximately 1 h. Results: Pathogens detected by FA caused approximately 75% of cases, 97% of which would be accurately diagnosed with FA. Mean cost/case ranged from $17,599 to $22,025. Syndromic testing is less expensive than SOC. Testing all suspected cases yielded greater savings ($3481/case) than testing only those with abnormal cerebrospinal fluid ($2157/case). Conclusion: Greater economic benefits are achievable with syndromic testing of all cases, rather than SOC or targeted syndromic testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Practice Guidelines for the Management of Bacterial Meningitis
Tunkel, A. R., Hartman, B. J., Kaplan, S. L., Kaufman, B. A., Roos, K. L., Scheld, W. M., & Whitley, R. J. (2004) · Clinical Infectious Diseases · doi:10.1086/425368 · Cited by 2,308
Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis
Brouwer, M. C., Tunkel, A. R., & van de Beek, D. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00070-09 · Cited by 930
ESCMID guideline: diagnosis and treatment of acute bacterial meningitis
van de Beek, D., Cabellos, C., Dzupova, O., Esposito, S., Klein, M., Kloek, A. T., Leib, S. L., Mourvillier, B., Ostergaard, C., Pagliano, P., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.01.007 · Cited by 919
Leber, A. L., Everhart, K., Balada-Llasat, J.-M., Cullison, J., Daly, J., Holt, S., Lephart, P., Salimnia, H., Schreckenberger, P. C., DesJarlais, S., et al. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00730-16 · Cited by 609
Self-citationRamers, C. (2000) · JAMA · doi:10.1001/jama.283.20.2680 · Cited by 291
McGill, F., Heyderman, R. S., Michael, B. D., Defres, S., Beeching, N. J., Borrow, R., Glennie, L., Gaillemin, O., Wyncoll, D., Kaczmarski, E., et al. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.01.007 · Cited by 254
Castelblanco, R. L., Lee, M., & Hasbun, R. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70805-9 · Cited by 245
Self-citationEpidemiology of meningitis and encephalitis in the United States, 2011–2014
Hasbun, R., Rosenthal, N., Balada-Llasat, J. M., Chung, J., Duff, S., Bozzette, S., Zimmer, L., & Ginocchio, C. C. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix319 · Cited by 171
Self-citation
Cited by
The challenge of diagnostic metagenomics
Greninger, A. L. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1487292 · Cited by 156
Vetter, P., Schibler, M., Herrmann, J. L., & Boutolleau, D. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.12.013 · Cited by 64
Boudet, A., Pantel, A., Carles, M.-J., Boclé, H., Charachon, S., Enault, C., Stéphan, R., Cadot, L., Lavigne, J.-P., & Marchandin, H. (2019) · PLOS ONE · doi:10.1371/journal.pone.0223887 · Cited by 49
Posnakoglou, L., Siahanidou, T., Syriopoulou, V., & Michos, A. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03986-6 · Cited by 42
Pfefferle, S., Christner, M., Aepfelbacher, M., Lütgehetmann, M., & Rohde, H. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-4904-4 · Cited by 36
Metadata
- Authors
- Duff, S., Hasbun, R., Ginocchio, C. C., Balada-Llasat, J.-M., Zimmer, L., & Bozzette, S. A.
- Venue
- Future Microbiology
- Publisher
- Informa UK Limited
- Published
- 2018-01-10
- Volume
- 13
- Issue
- 6
- Pages
- 617-629
- ISSN
- 1746-0913 (ISSN-L)
- 1746-0921
- OpenAlex
- W2783474636
- Cited by
- 31
- References
- 8
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.